Femoroacetabular Impingement Clinical Trial
Official title:
A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Hip
Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.
This study is designed as a post-market, single arm, non-randomized multi-center investigation. Male and female subjects, at least 18 years of age, with at least one subchondral bone defect in the form of a cyst and/or bone marrow lesion (BML), insufficiency fracture or bone defect associated with early stage avascular osteonecrosis (AVN) in the femoral head, femoral neck and/or acetabulum who are suitable candidates for use of AccuFill during the Subchondroplasty Procedure are eligible for enrollment in this study. A maximum of 15 study sites, in the United States of America, will enroll a target of 50 subjects. Each Investigator must obtain IRB approval, or favorable opinion by an EC, prior to consent of the first subject; no study-related procedures can occur without the approval and oversight of a registered IRB or EC. If the study site does not have an IRB of record, a central IRB may be utilized upon approval by Zimmer Biomet. Demographics, medical history, hip history and use of pain medication and therapy will be recorded at the time of subject consent. Additionally, patient reported outcomes measures will be obtained pre-operatively. Operative details including the SCP Procedure, concomitant surgical procedures and intraoperative safety events will be recorded at the time of surgery. Prospective subjects will be considered enrolled in this study once their Subchondroplasty Procedure has been performed. Subjects will complete only the Numeric Pain Scale at 2 weeks post-operatively. Thereafter, subjects will complete self-reported outcomes measures post-operatively at 6 weeks, 12 weeks, 6 months, 1 year and 2 years. These measures include information on pain medication and therapy, pain levels, function, activity and subject satisfaction. Screening for adverse events and conversion will occur throughout the study. Subjects will complete the study at 2 years or will be withdrawn if they undergo conversion of the Subchondroplasty site. For the purposes of this protocol, a conversion will be defined as total hip arthroplasty or any procedure involving removal of the AccuFill material on the index hip. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01623843 -
Femoroacetabular Impingement RandomiSed Controlled Trial
|
N/A | |
Completed |
NCT03669471 -
Muscular and Functional Performance in FAIS Patients
|
||
Not yet recruiting |
NCT05031390 -
the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study
|
N/A | |
Active, not recruiting |
NCT05025956 -
Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02674113 -
Regional Anesthesia in Hip Arthroscopy
|
N/A | |
Withdrawn |
NCT02260726 -
Evaluation of Ultrasound for Detecting Hip Impingement
|
N/A | |
Recruiting |
NCT05391204 -
Reproducibility of Strength Testing and Functional Testing of the Hip for the Return to Sport of Patients Activated by a Femoroacetabular Impingement: Comparison Between a Group of Patients and a Group of Healthy Controls
|
N/A | |
Active, not recruiting |
NCT03891563 -
Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip
|
||
Active, not recruiting |
NCT04069507 -
Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
|
||
Terminated |
NCT03278353 -
Fulfillment of Expectations for Patients With FAI Syndrome
|
N/A | |
Terminated |
NCT03995290 -
3D Modeling to Improve Hip Arthroscopy Outcomes
|
||
Completed |
NCT06082271 -
Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy
|
N/A | |
Recruiting |
NCT01621360 -
Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
|
N/A | |
Completed |
NCT04980209 -
The Feasibility and Application of Intraoperative Ultrasound to Evaluate Femoral Head Shaping
|
||
Enrolling by invitation |
NCT04988659 -
Analysis of Gene Expression in Femoroacetabular Impingement (FAI)
|
||
Active, not recruiting |
NCT04822571 -
Investigating the Reliability of Highly Dynamic 3D Motion Analysis Protocol in Adolescence and Adult Males
|
N/A | |
Withdrawn |
NCT02706756 -
Conservative Intervention of Femoroacetabular Impingement Syndrome
|
N/A | |
Completed |
NCT02702661 -
PRCT of FICB vs LAI for Hip Arthroscopy
|
N/A | |
Completed |
NCT01993615 -
A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial
|
N/A | |
Completed |
NCT01814124 -
Conservative Management of Femoroacetabular Impingement
|
N/A |